Effects of selective If-channel inhibition with ivabradine on hemodynamics in a patient with restrictive cardiomyopathy

Clinical Research in Cardiology

Volumn 98, Issue 10, 2009, Pages 681-684

  Wenzel, Philip ^a   Abegunewardene, Nico ^a   Münzel, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; FUROSEMIDE; IVABRADINE;

AGED; CASE REPORT; ELECTROCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART INDEX; HEART MUSCLE BIOPSY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RESTRICTIVE CARDIOMYOPATHY;

AGED; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; CARDIOMYOPATHY, RESTRICTIVE; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; HEART FAILURE; HEART RATE; HEMODYNAMICS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; TREATMENT OUTCOME;

EID: 70349554392     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0057-6     Document Type: Letter

References (10)

1. A Diaz MG Bourassa MC Guertin JC Tardif 2005 Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease Eur Heart J 26 967-974
2. G Flannery R Gehrig-Mills B Billah H Krum 2008 Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers Am J Cardiol 101 865-869
3. WB Kannel C Kannel RS Paffenbarger Jr LA Cupples 1987 Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1489-1494
4. RJ Gibbons J Abrams K Chatterjee J Daley PC Deedwania JS Douglas TB Ferguson Jr SD Fihn TD Fraker Jr JM Gardin RA O'Rourke RC Pasternak SV Williams 2003 ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina) J Am Coll Cardiol 41 159-168 (Pubitemid 36044419)
5. I Graham D Atar K Borch-Johnsen G Boysen G Burell R Cifkova J Dallongeville G De Backer S Ebrahim B Gjelsvik C Herrmann-Lingen A Hoes S Humphries M Knapton J Perk SG Priori K Pyorala Z Reiner L Ruilope S Sans-Menendez WS Op Reimer P Weissberg D Wood J Yarnell JL Zamorano E Walma T Fitzgerald MT Cooney A Dudina A Vahanian J Camm R De Caterina V Dean K Dickstein C Funck-Brentano G Filippatos I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano A Altiner E Bonora PN Durrington R Fagard S Giampaoli H Hemingway J Hakansson SE Kjeldsen ML Larsen G Mancia AJ Manolis K Orth-Gomer T Pedersen M Rayner L Ryden M Sammut N Schneiderman AF Stalenhoef L Tokgozoglu O Wiklund A Zampelas 2007 European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl 2 E1 40
6. K Fox I Ford PG Steg M Tendera R Ferrari 2008 Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 807-816
7. P Mulder S Barbier A Chagraoui V Richard JP Henry F Lallemand S Renet G Lerebours F Mahlberg-Gaudin C Thuillez 2004 Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure Circulation 109 1674-1679
8. Werdan K (2008) Die SHIFT-studie. In: Münzel T (ed) Bedeutung der Herzfrequenz in der Therapie kardiovaskulärer Erkrankungen. UNI-MED Verlag AG, Bremen, pp 52-54
9. JB Selvanayagam PN Hawkins B Paul SG Myerson S Neubauer 2007 Evaluation and management of the cardiac amyloidosis J Am Coll Cardiol 50 2101-2110
10. G Artz J Wynne 2000 Restrictive Cardiomyopathy Curr Treat Options Cardiovasc Med 2 431-438